List of Tables
Table 1. Antiallergics Drugs Market Trends
Table 2. Antiallergics Drugs Market Drivers & Opportunity
Table 3. Antiallergics Drugs Market Challenges
Table 4. Antiallergics Drugs Market Restraints
Table 5. Global Antiallergics Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antiallergics Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Antiallergics Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Antiallergics Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Antiallergics Drugs Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Antiallergics Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Antiallergics Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Antiallergics Drugs
Table 13. Global Antiallergics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiallergics Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Antiallergics Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Antiallergics Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Antiallergics Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Antiallergics Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Antiallergics Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Antiallergics Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Antiallergics Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Antiallergics Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Antiallergics Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Antiallergics Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Antiallergics Drugs Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Antiallergics Drugs Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Antiallergics Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Antiallergics Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Antiallergics Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Antiallergics Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Antiallergics Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Antiallergics Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Antiallergics Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Antiallergics Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Antiallergics Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Antiallergics Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Antiallergics Drugs Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Antiallergics Drugs Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Antiallergics Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Antiallergics Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Antiallergics Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Antiallergics Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Antiallergics Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Antiallergics Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Antiallergics Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Antiallergics Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Antiallergics Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Antiallergics Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Antiallergics Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Antiallergics Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Antiallergics Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Antiallergics Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Antiallergics Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Antiallergics Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Antiallergics Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Akorn Company Information
Table 58. Akorn Introduction and Business Overview
Table 59. Akorn Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Akorn Antiallergics Drugs Product Offerings
Table 61. Akorn Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Pfizer Antiallergics Drugs Product Offerings
Table 66. Pfizer Recent Development
Table 67. GSK plc Company Information
Table 68. GSK plc Introduction and Business Overview
Table 69. GSK plc Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. GSK plc Antiallergics Drugs Product Offerings
Table 71. GSK plc Recent Development
Table 72. Novartis AG Company Information
Table 73. Novartis AG Introduction and Business Overview
Table 74. Novartis AG Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Novartis AG Antiallergics Drugs Product Offerings
Table 76. Novartis AG Recent Development
Table 77. Mylan N.V. Company Information
Table 78. Mylan N.V. Introduction and Business Overview
Table 79. Mylan N.V. Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Mylan N.V. Antiallergics Drugs Product Offerings
Table 81. Mylan N.V. Recent Development
Table 82. Teva Pharmaceutical Industries Company Information
Table 83. Teva Pharmaceutical Industries Introduction and Business Overview
Table 84. Teva Pharmaceutical Industries Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Teva Pharmaceutical Industries Antiallergics Drugs Product Offerings
Table 86. Teva Pharmaceutical Industries Recent Development
Table 87. Sanofi Company Information
Table 88. Sanofi Introduction and Business Overview
Table 89. Sanofi Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Sanofi Antiallergics Drugs Product Offerings
Table 91. Sanofi Recent Development
Table 92. Boehringer Ingelheim International GmbH Company Information
Table 93. Boehringer Ingelheim International GmbH Introduction and Business Overview
Table 94. Boehringer Ingelheim International GmbH Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Boehringer Ingelheim International GmbH Antiallergics Drugs Product Offerings
Table 96. Boehringer Ingelheim International GmbH Recent Development
Table 97. AstraZeneca Company Information
Table 98. AstraZeneca Introduction and Business Overview
Table 99. AstraZeneca Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. AstraZeneca Antiallergics Drugs Product Offerings
Table 101. AstraZeneca Recent Development
Table 102. Johnson & Johnson Private Company Information
Table 103. Johnson & Johnson Private Introduction and Business Overview
Table 104. Johnson & Johnson Private Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Johnson & Johnson Private Antiallergics Drugs Product Offerings
Table 106. Johnson & Johnson Private Recent Development
Table 107. Bayer AG Company Information
Table 108. Bayer AG Introduction and Business Overview
Table 109. Bayer AG Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Bayer AG Antiallergics Drugs Product Offerings
Table 111. Bayer AG Recent Development
Table 112. Merck & Co. Company Information
Table 113. Merck & Co. Introduction and Business Overview
Table 114. Merck & Co. Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Merck & Co. Antiallergics Drugs Product Offerings
Table 116. Merck & Co. Recent Development
Table 117. Prestige Consumer Healthcare Company Information
Table 118. Prestige Consumer Healthcare Introduction and Business Overview
Table 119. Prestige Consumer Healthcare Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Prestige Consumer Healthcare Antiallergics Drugs Product Offerings
Table 121. Prestige Consumer Healthcare Recent Development
Table 122. F. Hoffmann-La Roche Company Information
Table 123. F. Hoffmann-La Roche Introduction and Business Overview
Table 124. F. Hoffmann-La Roche Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. F. Hoffmann-La Roche Antiallergics Drugs Product Offerings
Table 126. F. Hoffmann-La Roche Recent Development
Table 127. Bristol-Myers Squibb Company Company Information
Table 128. Bristol-Myers Squibb Company Introduction and Business Overview
Table 129. Bristol-Myers Squibb Company Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Bristol-Myers Squibb Company Antiallergics Drugs Product Offerings
Table 131. Bristol-Myers Squibb Company Recent Development
Table 132. Almirall Company Information
Table 133. Almirall Introduction and Business Overview
Table 134. Almirall Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Almirall Antiallergics Drugs Product Offerings
Table 136. Almirall Recent Development
Table 137. Zenomed Healthcare Private Company Information
Table 138. Zenomed Healthcare Private Introduction and Business Overview
Table 139. Zenomed Healthcare Private Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Zenomed Healthcare Private Antiallergics Drugs Product Offerings
Table 141. Zenomed Healthcare Private Recent Development
Table 142. Cadila Pharmaceuticals Company Information
Table 143. Cadila Pharmaceuticals Introduction and Business Overview
Table 144. Cadila Pharmaceuticals Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Cadila Pharmaceuticals Antiallergics Drugs Product Offerings
Table 146. Cadila Pharmaceuticals Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Antiallergics Drugs Downstream Customers
Table 150. Antiallergics Drugs Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiallergics Drugs Product Picture
Figure 2. Global Antiallergics Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antiallergics Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Antiallergics Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Antiallergics Drugs Sales Price (2019-2030) & (US$/Unit)
Figure 6. Antiallergics Drugs Report Years Considered
Figure 7. Global Antiallergics Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Antiallergics Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiallergics Drugs Revenue in 2023
Figure 10. Antiallergics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Antihistamines Picture
Figure 12. Corticosteroids Picture
Figure 13. Epinephrine Picture
Figure 14. Allergen Immunotherapy Picture
Figure 15. Decongestants Picture
Figure 16. Others Picture
Figure 17. Global Antiallergics Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Antiallergics Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 19. Global Antiallergics Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 20. Global Antiallergics Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 21. Global Antiallergics Drugs Price by Type (2019-2030) & (US$/Unit)
Figure 22. Product Picture of Hospital Pharmacy
Figure 23. Product Picture of Retail Pharmacy
Figure 24. Product Picture of Online Pharmacy
Figure 25. Global Antiallergics Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Antiallergics Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Antiallergics Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Antiallergics Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Antiallergics Drugs Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Antiallergics Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Antiallergics Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Antiallergics Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Antiallergics Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Antiallergics Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Antiallergics Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Antiallergics Drugs Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Antiallergics Drugs Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Antiallergics Drugs Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Antiallergics Drugs Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Antiallergics Drugs Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Antiallergics Drugs Sales Volume (%), (2019-2030)
Figure 42. United States Antiallergics Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Antiallergics Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Antiallergics Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Antiallergics Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Antiallergics Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Antiallergics Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. China Antiallergics Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Antiallergics Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. China Antiallergics Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Antiallergics Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Antiallergics Drugs Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Antiallergics Drugs Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Antiallergics Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Antiallergics Drugs Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Antiallergics Drugs Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Antiallergics Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Antiallergics Drugs Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Antiallergics Drugs Sales Value by Application (%), 2023 VS 2030
Figure 60. India Antiallergics Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Antiallergics Drugs Sales Value by Type (%), 2023 VS 2030
Figure 62. India Antiallergics Drugs Sales Value by Application (%), 2023 VS 2030
Figure 63. Antiallergics Drugs Industrial Chain
Figure 64. Antiallergics Drugs Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
